BioCentury
ARTICLE | Financial News

Storm Therapeutics raises L12M in series A round

June 29, 2016 1:43 AM UTC

Storm Therapeutics Ltd. (Cambridge, U.K.) raised L12 million ($16.1 million) in a series A round from existing investors Imperial Innovations Group plc (LSE:IVO), Cambridge Innovation Capital, Merck Ventures and Pfizer Venture Investments.

Spun out of the University of Cambridge's Gurdon Institute, Storm is developing small molecule modulators that target RNA-modifying enzymes to treat cancer. The modulators are in discovery. ...